Skip to content

Drug interactions

Eplerenone + Nirmatrelvir / ritonavir

Severity: Contraindicated

Eplerenone and Nirmatrelvir / ritonavir: contraindicated interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ritonavir in this combination strongly inhibits CYP3A4, greatly increasing eplerenone exposure and the risk of severe hyperkalemia. Eplerenone is contraindicated with strong CYP3A4 inhibitors.

What this interaction means in plain words

Eplerenone and Nirmatrelvir / ritonavir are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Evidence level: High

Why it happens

Strong ritonavir-mediated CYP3A4 inhibition reduces eplerenone metabolism.

What to do

Withhold eplerenone during the antiviral course and for a few days afterward as advised by current labeling, and check potassium and renal function if exposure occurs.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eplerenone and Nirmatrelvir / ritonavir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Eplerenone with Nirmatrelvir / ritonavir?

MediHelp rates the interaction as contraindicated. Eplerenone and Nirmatrelvir / ritonavir are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Ritonavir in this combination strongly inhibits CYP3A4, greatly increasing eplerenone exposure and the risk of severe hyperkalemia. Eplerenone is contraindicated with strong CYP3A4 inhibitors.

How serious is the interaction between Eplerenone and Nirmatrelvir / ritonavir?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Withhold eplerenone during the antiviral course and for a few days afterward as advised by current labeling, and check potassium and renal function if exposure occurs.

What other medicines interact with Eplerenone?

MediHelp also lists interactions of Eplerenone with, for example, Amiloride, Atazanavir, Clarithromycin. The full list is on the Eplerenone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in